These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

173 related articles for article (PubMed ID: 35794176)

  • 1. People with HIV have higher percentages of circulating CCR5+ CD8+ T cells and lower percentages of CCR5+ regulatory T cells.
    van Eekeren LE; Matzaraki V; Zhang Z; van de Wijer L; Blaauw MJT; de Jonge MI; Vandekerckhove L; Trypsteen W; Joosten LAB; Netea MG; de Mast Q; Koenen HJPM; Li Y; van der Ven AJAM
    Sci Rep; 2022 Jul; 12(1):11425. PubMed ID: 35794176
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The Architecture of Circulating Immune Cells Is Dysregulated in People Living With HIV on Long Term Antiretroviral Treatment and Relates With Markers of the HIV-1 Reservoir, Cytomegalovirus, and Microbial Translocation.
    Van de Wijer L; van der Heijden WA; Ter Horst R; Jaeger M; Trypsteen W; Rutsaert S; van Cranenbroek B; van Rijssen E; Joosten I; Joosten L; Vandekerckhove L; Schoofs T; van Lunzen J; Netea MG; Koenen HJPM; van der Ven AJAM; de Mast Q
    Front Immunol; 2021; 12():661990. PubMed ID: 33953724
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The number of CCR5 expressing CD4+ T lymphocytes is lower in HIV-infected long-term non-progressors with viral control compared to normal progressors: a cross-sectional study.
    Meijerink H; Indrati AR; van Crevel R; Joosten I; Koenen H; van der Ven AJ
    BMC Infect Dis; 2014 Dec; 14():683. PubMed ID: 25495598
    [TBL] [Abstract][Full Text] [Related]  

  • 4. CCR5 and CXCR4 expression on memory and naive T cells in HIV-1 infection and response to highly active antiretroviral therapy.
    Nicholson JK; Browning SW; Hengel RL; Lew E; Gallagher LE; Rimland D; McDougal JS
    J Acquir Immune Defic Syndr; 2001 Jun; 27(2):105-15. PubMed ID: 11404531
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Deep lung--cellular reaction to HIV].
    Tavares Marques MA; Alves V; Duque V; Botelho MF
    Rev Port Pneumol; 2007; 13(2):175-212. PubMed ID: 17492233
    [TBL] [Abstract][Full Text] [Related]  

  • 6. CC chemokine receptor 5 cell-surface expression in relation to CC chemokine receptor 5 genotype and the clinical course of HIV-1 infection.
    de Roda Husman AM; Blaak H; Brouwer M; Schuitemaker H
    J Immunol; 1999 Oct; 163(8):4597-603. PubMed ID: 10510404
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Selective lymphocyte chemokine receptor expression in the rheumatoid joint.
    Ruth JH; Rottman JB; Katschke KJ; Qin S; Wu L; LaRosa G; Ponath P; Pope RM; Koch AE
    Arthritis Rheum; 2001 Dec; 44(12):2750-60. PubMed ID: 11762935
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Impact of highly active antiretroviral treatment on expression of HIV-1 coreceptors and ligand levels in peripheral blood from HIV-1 infected patients in China.
    Fang J; Bai S; Wu L; Zhu X; Yao X; Jin C; Wang C
    J Int Med Res; 2013 Oct; 41(5):1560-9. PubMed ID: 24043708
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The intensity of immune activation is linked to the level of CCR5 expression in human immunodeficiency virus type 1-infected persons.
    Portales P; Psomas KC; Tuaillon E; Mura T; Vendrell JP; Eliaou JF; Reynes J; Corbeau P
    Immunology; 2012 Sep; 137(1):89-97. PubMed ID: 22862553
    [TBL] [Abstract][Full Text] [Related]  

  • 10. High levels of CD4⁺ CTLA-4⁺ Treg cells and CCR5 density in HIV-1-infected patients with visceral leishmaniasis.
    Vallejo A; Abad-Fernández M; Moreno S; Moreno A; Pérez-Elías MJ; Dronda F; Casado JL
    Eur J Clin Microbiol Infect Dis; 2015 Feb; 34(2):267-75. PubMed ID: 25142804
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Immunological profiles of HIV-positive recipients of liver transplant.
    Righi E; Ivaldi F; La Rosa A; Carnelutti A; Londero A; Bassetti M
    Transpl Immunol; 2019 Dec; 57():101208. PubMed ID: 31102654
    [TBL] [Abstract][Full Text] [Related]  

  • 12. HLA-DR+ CD38+ CD4+ T lymphocytes have elevated CCR5 expression and produce the majority of R5-tropic HIV-1 RNA in vivo.
    Meditz AL; Haas MK; Folkvord JM; Melander K; Young R; McCarter M; Mawhinney S; Campbell TB; Lie Y; Coakley E; Levy DN; Connick E
    J Virol; 2011 Oct; 85(19):10189-200. PubMed ID: 21813616
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Short-term antiretroviral therapy fails to reduce the expanded activated CCR5-expressing CD4+ T lymphocyte population or to restore the depleted naive population in chronically HIV-infected individuals with active pulmonary tuberculosis.
    Kabue JP; de Swardt D; de Beer C; Glashoff RH
    AIDS Res Hum Retroviruses; 2013 May; 29(5):769-77. PubMed ID: 23259904
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Breast milk CD4+ T cells express high levels of C chemokine receptor 5 and CXC chemokine receptor 4 and are preserved in HIV-infected mothers receiving highly active antiretroviral therapy.
    Kourtis AP; Ibegbu CC; Theiler R; Xu YX; Bansil P; Jamieson DJ; Lindsay M; Butera S; Duerr A
    J Infect Dis; 2007 Apr; 195(7):965-72. PubMed ID: 17330786
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Immune Activation and HIV-Specific CD8(+) T Cells in Cerebrospinal Fluid of HIV Controllers and Noncontrollers.
    Ganesh A; Lemongello D; Lee E; Peterson J; McLaughlin BE; Ferre AL; Gillespie GM; Fuchs D; Deeks SG; Hunt PW; Price RW; Spudich SS; Shacklett BL
    AIDS Res Hum Retroviruses; 2016 Aug; 32(8):791-800. PubMed ID: 27019338
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Severe immune dysregulation affects CD4⁺CD25(hi)FoxP3⁺ regulatory T cells in HIV-infected patients with low-level CD4 T-cell repopulation despite suppressive highly active antiretroviral therapy.
    Méndez-Lagares G; Pozo-Balado MM; Genebat M; García Pergañeda A; Leal M; Pacheco YM
    J Infect Dis; 2012 May; 205(10):1501-9. PubMed ID: 22457273
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Differences in T cell distribution and CCR5 expression in HIV-positive and HIV-exposed seronegative persons who inject drugs.
    Kallas E; Huik K; Türk S; Pauskar M; Jõgeda EL; Šunina M; Karki T; Des Jarlais D; Uusküla A; Avi R; Lutsar I
    Med Microbiol Immunol; 2016 Jun; 205(3):231-9. PubMed ID: 26696529
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Immune Correlates of Herpes Zoster in People Living with HIV on Effective Antiretroviral Therapy.
    Tovar Salazar A; McKhann A; Chen H; Bosch RJ; Weinberg A
    AIDS Res Hum Retroviruses; 2019 Oct; 35(10):890-895. PubMed ID: 31179712
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Positive association between beta-chemokine-producing T cells and HIV type 1 viral load in HIV-infected subjects in Abidjan, Côte d'Ivoire.
    Jennes W; Sawadogo S; Koblavi-Dème S; Vuylsteke B; Maurice C; Roels TH; Chorba T; Nkengasong JN; Kestens L
    AIDS Res Hum Retroviruses; 2002 Feb; 18(3):171-7. PubMed ID: 11839151
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Decreased HIV type 1 transcription in CCR5-Δ32 heterozygotes during suppressive antiretroviral therapy.
    Wang C; Abdel-Mohsen M; Strain MC; Lada SM; Yukl S; Cockerham LR; Pilcher CD; Hecht FM; Sinclair E; Liegler T; Richman DD; Deeks SG; Pillai SK
    J Infect Dis; 2014 Dec; 210(11):1838-43. PubMed ID: 24935955
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.